Cevimeline hydrochloride
Cevimeline Hydrochloride is a prescription oral capsule medication containing 30 mg of the active ingredient, used as a cholinergic muscarinic agonist to stimulate certain receptors. Manufactured by Hikma Pharmaceuticals USA Inc. and distributed by Bryant Ranch Prepack, it's available in bottles of 30, 60, or 90 capsules. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Cevimeline Hydrochloride is a prescription oral capsule medication containing 30 mg of the active ingredient, used as a cholinergic muscarinic agonist to stimulate certain receptors. Manufactured by Hikma Pharmaceuticals USA Inc. and distributed by Bryant Ranch Prepack, it's available in bottles of 30, 60, or 90 capsules. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Cevimeline hydrochloride",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Cevimeline hydrochloride — ANDA 020989 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020989"
}
]
|
| identifier | ANDA020989 |
| issued | 2016-09-16 |
| keyword |
[
"drug-safety",
"fda",
"health-care",
"medications",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Cevimeline hydrochloride |
